Hasil Pencarian - David W. Hines

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Performance of the quick COVID-19 severity index and the Brescia-COVID respiratory severity scale in hospitalized patients with COVID-19 in a community hospital setting

    Performance of the quick COVID-19 severity index and the Brescia-COVID respiratory severity scale in hospitalized patients with COVID-19 in a community hospital setting oleh Guillermo Rodriguez-Nava, Maria Adriana Yanez-Bello, Daniela Patricia Trelles-Garcia, Chul Won Chung, Harvey J. Friedman, David W. Hines

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Clinical Characteristics and Risk Factors for Death of Hospitalized Patients With COVID-19 in a Community Hospital: A Retrospective Cohort Study

    Clinical Characteristics and Risk Factors for Death of Hospitalized Patients With COVID-19 in a Community Hospital: A Retrospective Cohort Study oleh Guillermo Rodriguez-Nava, MD, Maria Adriana Yanez-Bello, MD, Daniela Patricia Trelles-Garcia, MD, Chul Won Chung, MD, Sana Chaudry, MD, Aimen S. Khan, MD, Harvey J. Friedman, MD, FACP, David W. Hines, MD

    Diterbitkan 2021-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Early Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2

    Early Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2 oleh Russell M. Petrak, MD, Nicholas W. Van Hise, PharmD, Nathan C. Skorodin, PharmD, Robert M. Fliegelman, DO, Vishnu Chundi, MD, Vishal Didwania, MD, Alice Han, MD, Brian P. Harting, MD, David W. Hines, MD

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2

    Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2 oleh Russell M. Petrak, Nathan C. Skorodin, Nicholas W. Van Hise, Robert M. Fliegelman, Jonathan Pinsky, Vishal Didwania, Michael Anderson, Melina Diaz, Kairav Shah, Vishnu V. Chundi, David W. Hines, Brian P. Harting, Kamo Sidwha, Brian Yu, Paul Brune, Anjum Owaisi, David Beezhold, Joseph Kent, Dana Vais, Alice Han, Neethi Gowda, Nishi Sahgal, Jan Silverman, Jonathan Stake, Jenie Nepomuceno, Renuka Heddurshetti

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: